CN116635393A - 中环或大环苄基取代的杂环衍生物及其作为食欲素-2受体激动剂的用途 - Google Patents
中环或大环苄基取代的杂环衍生物及其作为食欲素-2受体激动剂的用途 Download PDFInfo
- Publication number
- CN116635393A CN116635393A CN202180074185.9A CN202180074185A CN116635393A CN 116635393 A CN116635393 A CN 116635393A CN 202180074185 A CN202180074185 A CN 202180074185A CN 116635393 A CN116635393 A CN 116635393A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- compound
- alkenyl
- certain embodiments
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074220P | 2020-09-03 | 2020-09-03 | |
| US63/074220 | 2020-09-03 | ||
| PCT/US2021/049003 WO2022051583A1 (en) | 2020-09-03 | 2021-09-03 | Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and their uses as orexin-2 receptor agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116635393A true CN116635393A (zh) | 2023-08-22 |
Family
ID=78078371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180074185.9A Pending CN116635393A (zh) | 2020-09-03 | 2021-09-03 | 中环或大环苄基取代的杂环衍生物及其作为食欲素-2受体激动剂的用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230331720A1 (https=) |
| EP (1) | EP4208465A1 (https=) |
| JP (1) | JP7811578B2 (https=) |
| CN (1) | CN116635393A (https=) |
| TW (1) | TW202227433A (https=) |
| WO (1) | WO2022051583A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4065585B1 (en) | 2019-11-25 | 2025-08-20 | Alkermes, Inc. | Substituted macrocyclic compounds and related methods of treatment |
| CN116583502A (zh) | 2020-09-03 | 2023-08-11 | 欧瑞夏治疗有限公司 | 二环-杂环衍生物及其作为食欲素-2受体激动剂的用途 |
| US11760747B2 (en) | 2020-12-21 | 2023-09-19 | Alkermes, Inc. | Substituted piperidino compounds and related methods of treatment |
| US12006330B2 (en) | 2020-12-21 | 2024-06-11 | Alkermes, Inc. | Substituted macrocyclic compounds and related methods of treatment |
| AU2022280804A1 (en) * | 2021-05-26 | 2023-11-30 | Alkermes, Inc. | Substituted carbamate macrocyclic compounds and related methods of treatment |
| JP2025507852A (ja) * | 2022-03-01 | 2025-03-21 | センテッサ ファーマシューティカルズ （ユーケー） リミテッド | 中環状または大環状ベンジル置換複素環誘導体および関連の使用 |
| IL316468A (en) * | 2022-04-22 | 2024-12-01 | Teijin Pharma Ltd | The aftermath of oxazepine |
| CN114716319B (zh) * | 2022-04-28 | 2024-03-26 | 浙江工业大学 | 一种联芳氧基烯酸酯类化合物的合成方法 |
| WO2024075825A1 (ja) * | 2022-10-07 | 2024-04-11 | キッセイ薬品工業株式会社 | シクロペンタン化合物 |
| EP4611745A1 (en) | 2022-10-31 | 2025-09-10 | Takeda Pharmaceutical Company Limited | Dosing of orexin type 2 receptor agonists |
| PE20252742A1 (es) | 2023-03-16 | 2025-12-05 | Takeda Pharmaceuticals Co | Compuestos heterociclicos macrociclicos y sus usos |
| IL324946A (en) | 2023-06-01 | 2026-01-01 | H Lundbeck As | Spiro-macrocyclic orexin 2 receptor agonists |
| EP4719397A1 (en) | 2023-06-02 | 2026-04-08 | Takeda Pharmaceutical Company Limited | Use of an orexin 2 receptor agonist for improving respiratory function during sleep |
| TW202535890A (zh) * | 2023-10-20 | 2025-09-16 | 日商帝人製藥股份有限公司 | 氧氮呯衍生物之結晶或其溶劑合物之結晶 |
| WO2025124698A1 (en) | 2023-12-12 | 2025-06-19 | Idorsia Pharmaceuticals Ltd | Aryl sulfone and sulfanone derivatives as orexin receptor modulators |
| TW202542165A (zh) | 2023-12-19 | 2025-11-01 | 瑞士商愛杜西亞製藥有限公司 | 大環食慾素激動劑 |
| WO2025229493A1 (en) | 2024-04-29 | 2025-11-06 | Takeda Pharmaceutical Company Limited | Dosing of orexin type 2 receptor agonists |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101880276A (zh) * | 2006-12-01 | 2010-11-10 | 默沙东公司 | 作为食欲素受体拮抗剂的取代的二氮杂环庚烷化合物 |
| CN111051295A (zh) * | 2017-08-03 | 2020-04-21 | 武田药品工业株式会社 | 杂环化合物及其用途 |
| WO2020158958A1 (en) * | 2019-01-31 | 2020-08-06 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| EP4065585B1 (en) * | 2019-11-25 | 2025-08-20 | Alkermes, Inc. | Substituted macrocyclic compounds and related methods of treatment |
-
2021
- 2021-09-03 JP JP2023515095A patent/JP7811578B2/ja active Active
- 2021-09-03 CN CN202180074185.9A patent/CN116635393A/zh active Pending
- 2021-09-03 TW TW110132882A patent/TW202227433A/zh unknown
- 2021-09-03 EP EP21786656.5A patent/EP4208465A1/en active Pending
- 2021-09-03 US US18/024,236 patent/US20230331720A1/en active Pending
- 2021-09-03 WO PCT/US2021/049003 patent/WO2022051583A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101880276A (zh) * | 2006-12-01 | 2010-11-10 | 默沙东公司 | 作为食欲素受体拮抗剂的取代的二氮杂环庚烷化合物 |
| CN111051295A (zh) * | 2017-08-03 | 2020-04-21 | 武田药品工业株式会社 | 杂环化合物及其用途 |
| WO2020158958A1 (en) * | 2019-01-31 | 2020-08-06 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
Non-Patent Citations (1)
| Title |
|---|
| 杨妙;邓康;: "食欲素受体拮抗剂的研究进展", 天津药学, no. 05, 28 October 2017 (2017-10-28), pages 69 - 73 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022051583A1 (en) | 2022-03-10 |
| EP4208465A1 (en) | 2023-07-12 |
| JP2023540350A (ja) | 2023-09-22 |
| TW202227433A (zh) | 2022-07-16 |
| JP7811578B2 (ja) | 2026-02-05 |
| US20230331720A1 (en) | 2023-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN116635393A (zh) | 中环或大环苄基取代的杂环衍生物及其作为食欲素-2受体激动剂的用途 | |
| US12503475B2 (en) | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists | |
| CN103097364B (zh) | 作为s1p调节剂的螺-哌啶衍生物 | |
| WO2025072451A1 (en) | Ras-pi3k inhibitors for the treatment of cancer and immunological diseases | |
| TW201920115A (zh) | 化合物、組合物及方法 | |
| WO2024182404A1 (en) | 1-(([1, 1',-biphenyl]-2-yl)sulfonyl)-4-fluoro-n-(3-(methylsulfonyl)allyl)piperidine-4-carboxamide derivatives as ras-pi3k modulators for the treatment of e.g. cancer | |
| CN111699180A (zh) | 作为lpa拮抗剂的吡唑n-连接的氨基甲酰基环己基酸 | |
| CN119110802A (zh) | 中环或大环苄基取代的杂环衍生物和相关用途 | |
| CN114599648A (zh) | 作为lpa拮抗剂的三唑羧酸 | |
| CN119156375A (zh) | 双环杂环衍生物和相关用途 | |
| WO2019179515A1 (zh) | 受体抑制剂、包含其的药物组合物及其用途 | |
| TW202515851A (zh) | Keap1抑制劑及其用途 | |
| CN114761383A (zh) | 磺酰胺衍生物及其用途 | |
| KR102865307B1 (ko) | 수용체 억제제, 이를 포함하는 약학적 조성물 및 그 용도 | |
| KR20240130749A (ko) | Bcl-2 저해제 | |
| TWI915407B (zh) | Ａｐｏｌ１抑制劑及其使用方法 | |
| CN107922426B (zh) | 四氢噁庚英吡啶化合物 | |
| EA052303B1 (ru) | Средне- или макроциклические производные бензилзамещенного гетероцикла и связанные с ними применения | |
| HK40111671A (zh) | 铁死亡调节剂、其制备和用途 | |
| HK40032239A (en) | Receptor inhibitors, pharmaceutical compositions comprising the same and use thereof | |
| HK40029777A (en) | Receptor inhibitor, pharmaceutical composition comprising same, and use thereof | |
| HK1184153B (en) | Spiro-cyclic amine derivatives as s1p modulators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| CB02 | Change of applicant information | ||
| CB02 | Change of applicant information |
Address after: Cheshire Applicant after: Sentesa Pharmaceuticals (Oresa) Co.,Ltd. Address before: London Applicant before: Ouruixia Treatment Co.,Ltd. |
|
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20240218 Address after: Cheshire Applicant after: Sentesa Pharmaceuticals (UK) Ltd. Country or region after: United Kingdom Address before: Cheshire Applicant before: Sentesa Pharmaceuticals (Oresa) Co.,Ltd. Country or region before: United Kingdom |